Extended-pulsed fidaxomicin regimen for treatment of C difficile infection maintained fidaxomicin stool concentrations above the minimum inhibitory concentration required to inhibit the growth of 90% of organisms for 26 days.
The global incidence of suspected or proven infection among patients admitted to the intensive care unit (ICU) was high in September 2017.
There remains considerable uncertainty on whether antibiotic prophylaxis for spontaneous bacterial peritonitis is beneficial in people with liver cirrhosis.
Older age is associated with an increased risk for bacteremia in hospitalized patients with inflammatory bowel disease (IBD).
From 2011 to 2017, there was a decrease in the estimated national burden of Clostridium difficile infection.
Cavitation, low density areas, and stenosis of responsible bronchus are risk factors for infectious complications after endobronchial ultrasound-guided transbronchial biopsy.
The point-of-care Dual Path Platform (DPP®) assay may be an inexpensive tool for the diagnosis of neurosyphilis.
Large variations in Clostridioides difficile infection risk resulting from antibiotic courses used for the same indications were identified.
The prevalence of H pylori infection continues to fall in the general population with only 16% of all gastric and 25% of all duodenal patients with ulcer harboring H pylori.
Adherence to antimalarials may offer a protective effect against type 2 diabetes mellitus among patients with systemic lupus erythematosus.
